Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lyngborg

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Ugeskrift for Laeger|August 7, 1989
[Levomepromazine (Nozinan) and pain therapy in acute myocardial infarction]F E Nielsen, S L Nielsen, F Knudsen, et al.
Danish Medical Bulletin|February 1, 1988
Prenalterol in severe congestive heart failure. II. Long-term oral treatment. Results with comments on the methods for evaluation of drugs in congestive heart failureM Tangø, K Lyngborg, C Jespersen, et al.
Danish Medical Bulletin|February 1, 1988
Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerineM Tangø, J Trap-Jensen, M Rehling, et al.
International Journal of Cardiology|January 1, 1992
Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised studyM Tangø, K Lyngborg, J Mehlsen, et al.
Cardiology|January 1, 1974
Terminal myocardial infarction. A prospective studyJ A Andersen, R Donde, B Fischer-Hansen, et al.
Computers and Biomedical Research, an International Journal|October 1, 1972
A method for systematic assessment of the relative prognostic significance of symptoms and signs in patients with a chronic disease. I. Description of model and selection of prognostically significant symptoms and signsP Winkel, K Lyngborg, K H Olesen, et al.
Computers and Biomedical Research, an International Journal|October 1, 1973
A method for systematic assessment of the relative prognostic significance of symptoms and signs in patients with a chronic disease. II. Analysis of validity of model and derivation of major prognostic stagesP Winkel, K Lyngborg, K H Olesen, et al.
British Journal of Clinical Pharmacology|January 1, 1987
Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart diseaseJ Bonde, T L Svendsen, K Lyngborg, et al.
Ugeskrift for Laeger|July 15, 1985
[Sudden death from ischemic heart disease in the community of Frederiksberg]E Kassis, J Tripax, A Frost, et al.
Danish Medical Bulletin|May 1, 1985
Myocardial infarction and cerebral infarction in a Danish suburban communityK Lyngborg, J Marquardsen, F Trautner, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Ugeskrift for Laeger|August 7, 1989
[Levomepromazine (Nozinan) and pain therapy in acute myocardial infarction]F E Nielsen, S L Nielsen, F Knudsen, et al.
Danish Medical Bulletin|February 1, 1988
Prenalterol in severe congestive heart failure. II. Long-term oral treatment. Results with comments on the methods for evaluation of drugs in congestive heart failureM Tangø, K Lyngborg, C Jespersen, et al.
Danish Medical Bulletin|February 1, 1988
Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerineM Tangø, J Trap-Jensen, M Rehling, et al.
International Journal of Cardiology|January 1, 1992
Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised studyM Tangø, K Lyngborg, J Mehlsen, et al.
Cardiology|January 1, 1974
Terminal myocardial infarction. A prospective studyJ A Andersen, R Donde, B Fischer-Hansen, et al.
Computers and Biomedical Research, an International Journal|October 1, 1972
A method for systematic assessment of the relative prognostic significance of symptoms and signs in patients with a chronic disease. I. Description of model and selection of prognostically significant symptoms and signsP Winkel, K Lyngborg, K H Olesen, et al.
Computers and Biomedical Research, an International Journal|October 1, 1973
A method for systematic assessment of the relative prognostic significance of symptoms and signs in patients with a chronic disease. II. Analysis of validity of model and derivation of major prognostic stagesP Winkel, K Lyngborg, K H Olesen, et al.
British Journal of Clinical Pharmacology|January 1, 1987
Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart diseaseJ Bonde, T L Svendsen, K Lyngborg, et al.
Ugeskrift for Laeger|July 15, 1985
[Sudden death from ischemic heart disease in the community of Frederiksberg]E Kassis, J Tripax, A Frost, et al.
Danish Medical Bulletin|May 1, 1985
Myocardial infarction and cerebral infarction in a Danish suburban communityK Lyngborg, J Marquardsen, F Trautner, et al.
Pageof 4